FIGARO-DKD and FIDELITY Analysis: Key Takeaways - a podcast by ReachMD

CME credits: 0.25

Valid until: 31-08-2022

Claim your CME credit at https://reachmd.com/programs/cme/figaro-dkd-and-fidelity-analysis-key-takeaways/12827/

Two HOT LINE sessions presented at the ESC Congress 2021 may change the way you manage your patients with diabetes and CKD as you work to prevent their progression to ESRD and improve their cardiovascular outcomes. Drs. Rajiv Agarwal, George Bakris, and Bertram Pitt review data from the FIGARO-DKD trial and the FIDELITY Analysis to explore the evolving role of mineralocorticoid receptor antagonists (MRAs) as part of the overall treatment plan for patients with diabetes and CKD. Don’t miss this potentially practice-changing session!

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD